Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allosteric modulation of GPCRs: From structural insights to in silico drug discovery
Margherita Persechino, Janik B. Hedderich, Peter Kolb, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108242-108242
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways
David Aranda-García, Tomasz Maciej Stępniewski, Mariona Torrens‐Fontanals, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands
А. О. Шпаков
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6187-6187
Open Access | Times Cited: 27
The application of artificial intelligence to accelerate G protein‐coupled receptor drug discovery
Thi Nguyen, Diep Thi Ngoc Nguyen, Huan Yee Koh, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 14, pp. 2371-2384
Open Access | Times Cited: 22
A µ-opioid receptor modulator that works cooperatively with naloxone
Evan S. O’Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Nature (2024) Vol. 631, Iss. 8021, pp. 686-693
Closed Access | Times Cited: 14
GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
Wessel A. C. Burger, Vi Pham, Ziva Vuckovic, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Network pharmacology and molecular docking: combined computational approaches to explore the antihypertensive potential of Fabaceae species
Zainab Shahzadi, Zubaida Yousaf, İrfan Anjum, et al.
Bioresources and Bioprocessing (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
The impact of cryo-EM on determining allosteric modulator-bound structures of G protein-coupled receptors
Liudi Zhang, Jesse I. Mobbs, Lauren T. May, et al.
Current Opinion in Structural Biology (2023) Vol. 79, pp. 102560-102560
Open Access | Times Cited: 13
INFLUENCE OF DIFFERENT TYPES OF ALLOSTERIC REGULATORS ON THE BASAL AND HORMONE-STIMULATED ACTIVITY OF THE THYROID-STIMULATED HORMONE RECEPTOR IN VITRO AND IN VIVO
К. В. Деркач, Е. А. Шпакова, E. A. Didenko, et al.
Reviews on Clinical Pharmacology and Drug Therapy (2025)
Closed Access
Investigating the functional dynamics of glyceraldehyde-3-phosphate dehydrogenase upon ligand binding at the putative allosteric binding sites
Merve Yuce, Özge Kürkçüoğlu
Biophysical Chemistry (2025) Vol. 320-321, pp. 107420-107420
Closed Access
A bio. tools collection of online resources for GPCR research
Tõnis Laasfeld, Friederike Wunsch, Avgi E. Apostolakou, et al.
British Journal of Pharmacology (2025)
Open Access
Structural insights into lipid chain-length selectivity and allosteric regulation of FFA2
Mai Kugawa, Kouki Kawakami, Ryoji Kise, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Ligand selectivity hotspots in serotonin GPCRs
Ícaro A. Simon, Walden E. Bjørn‐Yoshimoto, Kasper Harpsøe, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 12, pp. 978-990
Open Access | Times Cited: 12
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures
Hanbo Yao, Xiaodong Wang, Jiaxin Chi, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 964-964
Open Access | Times Cited: 4
Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Potential
S. Reinach Peter, Lydia Siragusa, Morgan Thomas, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 21, pp. 8176-8192
Open Access | Times Cited: 4
Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery
Mingyang Zhang, Xiaobing Lan, Xiaolong Li, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103803-103803
Closed Access | Times Cited: 10
Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands
Sara Abouelasrar Salama, Mieke Gouwy, Jo Van Damme, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Discovery and characterization of small-molecule TGR5 ligands with agonistic activity
Μάνθος Γ. Παπαδόπουλος, Alexander F. Perhal, Brian Medel-Lacruz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116616-116616
Open Access | Times Cited: 2
Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
Agnieszka A. Kaczor, Tomasz M. Wróbel, Damian Bartuzi
Molecules (2022) Vol. 28, Iss. 1, pp. 178-178
Open Access | Times Cited: 11
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands
А. О. Шпаков
(2023)
Open Access | Times Cited: 4
The path to the G protein‐coupled receptor structural landscape: Major milestones and future directions
Małgorzata M. Kogut, Zeenat Zara, Alessandro Nicoli, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Allosteric Sites and Allosteric Regulators of G Protein-Coupled Receptors: Gray Cardinals of Signal Transduction
А. О. Шпаков
Journal of Evolutionary Biochemistry and Physiology (2023) Vol. 59, Iss. S1, pp. S1-S106
Closed Access | Times Cited: 2
Exploring an Intracellular Allosteric Site of CC-Chemokine Receptor 4 from 3D Models, Probe Simulations, and Mutagenesis
Tianyi Ding, Abdul-Akim Guseinov, Graeme Milligan, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2516-2526
Open Access
GABAB Receptor Positive Allosteric Modulators: Novel Approaches for Drug Design and Discovery
Linn Samira Mari Evenseth
˜The œReceptors (2024), pp. 201-217
Closed Access
Agonists and Antagonists of Membrane-Bound Receptors
G. Klebe
Springer eBooks (2024), pp. 537-560
Closed Access
Page 1 - Next Page

Scroll to top